As a Singaporean-Chinese teenager growing up in London, the following situation is all too common. You're at a party. Two sips into a drink and your eyelids turn bright red, followed by your cheeks, and then your heart starts racing, and eventually nausea, while everyone around you looks completely fine. For roughly 540 million people worldwide, predominantly of East Asian descent, this is a familiar experience. Most people assume it is a sensitivity to alcohol, or perhaps an allergy. However, asian flush is the visible symptom of a genetic variant that disrupts one of the most critical detoxification pathways in the human body, with consequences that extend well beyond an embarrassing blush.
How Your Body Normally Processes Alcohol
When you drink, ethanol is absorbed through the stomach and small intestine into the bloodstream and carried to the liver, where the bulk of alcohol metabolism takes place. First, an enzyme called alcohol dehydrogenase (ADH) converts ethanol into acetaldehyde, a highly reactive, toxic compound. Next, another enzyme called aldehyde dehydrogenase 2 (ALDH2) rapidly converts acetaldehyde into acetate, which is a largely harmless molecule that is eventually broken down into carbon dioxide and water and cleared from the body.
Under normal circumstances, this two-step process is efficient. Acetaldehyde is cleared quickly before it can accumulate to dangerous levels, and most of the unpleasant effects of drinking, the nausea, the headache, the flushed skin, are kept at bay. The critical point to understand is that it is acetaldehyde, not ethanol itself, that is responsible for most of alcohol's harmful effects. ALDH2 is the enzyme standing between you and acetaldehyde toxicity. In people with Asian flush, that enzyme is barely functional.
What's Different
In roughly 35–40% of East Asian populations, a single nucleotide polymorphism, a change at one position in the DNA sequence, in the ALDH2 gene produces a variant called ALDH2*2. This mutation involves the substitution of a single amino acid as glutamate is replaced by lysine at position 487 of the enzyme. It is a tiny change in a protein that is 517 amino acids long. However, as a protein's function depends so critically on three-dimensional structure, and because that structure depends on the sequence of amino acids, this single substitution is enough to dramatically reduce the enzyme's ability to do its job.
The variant is autosomal dominant, meaning that inheriting just one copy from one parent is sufficient to reduce ALDH2 activity by around 75%. Inheriting two copies reduces activity by around 95%, often making even small amounts of alcohol physiologically intolerable. Approximately 540 million people carry at least one copy of ALDH2*2, making it one of the most common functional genetic variants in the entire human population.
Notably, the variant is found almost exclusively in East Asian populations, Han Chinese, Japanese, and Korean populations in particular, and is virtually absent in European and African populations. This distribution suggests the mutation arose from a single event in East Asia thousands of years ago and spread through the population over generations. Why it persisted at such high frequency remains an open question in population genetics, and one possible explanation is that the reduced alcohol tolerance it confers may have offered some protective advantage in certain historical contexts.
The Role of Acetaldehyde
With ALDH2 activity severely impaired, acetaldehyde accumulates rapidly in the bloodstream after drinking, a compound you do not want accumulating anywhere in your body.
In the skin and surrounding tissue, acetaldehyde triggers mast cell degranulation, the same process at the heart of the bee sting inflammatory response. Mast cells release a flood of stored histamine into surrounding tissue. Histamine binds to receptors on the walls of blood vessels in the face, causing vasodilation (the widening of the capillaries) which produces the characteristic bright red flush. The same histamine release also contributes to the nausea, headache, and itching that accompany the reaction.
Meanwhile, elevated acetaldehyde drives a rapid increase in heart rate (tachycardia) partly through direct effects on cardiac tissue and partly through the release of hormones such as adrenaline. The bigger picture is one of systemic acetaldehyde toxicity: the body is being flooded with a reactive compound it cannot efficiently clear, and the flush is simply the most visible sign of that toxicity.
The Antihistamine Myth
A workaround that has become increasingly popular, particularly in university culture, is taking an antihistamine such as cetirizine or famotidine before drinking. The logic is straightforward: if histamine is causing the flush, blocking histamine receptors should prevent it. And it works. The redness is reduced, the reaction is less visible, and the person can drink without obvious symptoms.
But here is the critical problem: antihistamines do nothing to combat acetaldehyde accumulation. They block the histamine receptors that produce the visible symptoms, but the underlying cause, toxic levels of acetaldehyde building up in the blood, continues entirely unimpeded. The flush is not just an inconvenience, it is a biological warning signal, the body's way of communicating that something is going seriously wrong.
People who suppress the flush pharmacologically may drink significantly more than they otherwise would, exposing themselves to higher levels of acetaldehyde for longer periods, potentially worsening the underlying cause. The antihistamine does not make drinking safer for someone with ALDH2*2. It makes it feel safer, which is a different and more dangerous thing entirely.
The More Dangerous Risk
Acetaldehyde is classified as a Group 1 carcinogen by the International Agency for Research on Cancer, the highest risk category, shared with tobacco smoke and asbestos.
The mechanism of carcinogenicity is direct and well understood. Acetaldehyde reacts with DNA bases to form acetaldehyde-DNA adducts, covalent bonds between acetaldehyde molecules and the nucleotide bases that make up the DNA sequence. If these structures are not repaired before the cell divides, they cause mutations which results in cancer if the mutation occurs in the wrong genes.
For people with ALDH2*2 who drink regularly, the most significantly elevated risk is of oesophageal cancer, as the tissue of the oesophagus is directly exposed to high concentrations of acetaldehyde as alcohol is swallowed and metabolised. Studies suggest that ALDH2*2 carriers who drink regularly face an oesophageal cancer risk up to 6–10 times higher than people with normal ALDH2 function consuming the same amount of alcohol. The risk is dose-dependent as more alcohol means more acetaldehyde accumulation, more DNA adduct formation, and a higher probability of carcinogenic mutation.
What Should You Do With This Information?
If you experience Asian flush like me, you almost certainly carry at least one copy of ALDH2*2. The informed response is not to suppress the flush with antihistamines but to drink significantly less, or to reconsider drinking altogether. Research into pharmacological solutions is ongoing. A small molecule called Alda-1 has shown promise in laboratory studies as an ALDH2 activator, a compound that could partially restore enzyme function in ALDH2*2 carriers by stabilising the mutant enzyme's structure. It has not yet reached clinical use, but it represents an exciting direction in the field of pharmacogenomics — the idea that individual genetic variation should inform how substances, including drugs, are prescribed and consumed.
Emily Jong